Related Experiment Video
Updated: Dec 30, 2025
09:14
Cardiac Magnetic Resonance Imaging at 7 Tesla
Published on: January 6, 2019
12.1K
Multivisceral Transplant, The Prince Charles Hospital Experience
Fiona E Doig1, Rishendran Naidoo1, Joseph Hwang1
1Department of Cardiothoracic Surgery, The Prince Charles Hospital, Chermside, Brisbane, Qld, Australia.
Heart, Lung & Circulation
|January 25, 2020
Summary
Multi-visceral organ transplantation outcomes in Australia show long-term survival and organ function comparable to international benchmarks. Waitlist times for these rare procedures were not excessive, indicating effective management.
Area of Science:
- Transplantation immunology
- Surgical outcomes research
- Organ replacement therapies
Background:
- Multi-visceral organ transplantation is a rare procedure with limited outcome data.
- Understanding patient complications and survival is crucial for improving care.
Purpose of the Study:
- To assess indications for multi-visceral organ transplant.
- To evaluate wait-list times and post-transplant outcomes in Australia.
- To identify patient survival, graft survival, and postoperative complications.
Main Methods:
- Retrospective review of 37 patients undergoing multi-visceral transplant from 1993-2018.
- Analysis of baseline characteristics, post-transplant morbidity, mortality, and graft survival.
Main Results:
- Included 22 heart-lung, 8 heart-kidney, and 7 heart-lung-liver transplants.
- One-year survival rates ranged from 86% to 91%.
- Five- and ten-year survival varied by transplant type, with heart-lung transplant showing 79% and heart-kidney 87.5%.
Conclusions:
- Australian multi-visceral transplant recipients demonstrate long-term survival and organ function comparable to global data.
- Waitlist times for these complex procedures were found to be reasonable.